The Board of Directors of Laurus Labs is scheduled to meet on October 23, 2025, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2025. The board will also consider a proposal for the payment of an Interim Dividend for FY 2025-26 and the determination of the record date for shareholder eligibility, subject to approval.
Board Meeting Scheduled
A meeting of the Board of Directors of Laurus Labs will be held on Thursday, October 23, 2025. The primary agenda includes the review and approval of key financial results and dividend considerations.
Financial Results Review
The board will consider and approve the un-audited financial results of the company for the quarter and half-year which concluded on September 30, 2025.
Interim Dividend Consideration
The Board of Directors will evaluate the proposal for the payment of an Interim Dividend for the financial year 2025-26. This includes the determination of a record date to establish eligibility for shareholders to receive the dividend if the proposal is approved.
Trading Window Closure
The company’s trading window, which restricts trading in company securities by Directors and Designated Persons, has been closed since October 1, 2025, and will remain closed until October 25, 2025 (inclusive). The initial intimation for this closure was made on September 26, 2025.
Source: BSE
